hg_101153.1

Basic information about the TSS

---

TSS ID: hg_101153.1 Species: human Chr: chr9		Start: 83708213 End: 83708249 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: LF384925 MA620502 Distance: -4 GeneID: 29979 HGNC/MGI_ID: HGNC:12508 UniProt_ID: Q9UMX0

Gene_name: LOC105376114 Gene_symbol: UBQLN1 Gene_synonyms: DA41 DSK2 PLIC-1 XDRP1 Gene_source: HGNC:12508

TATA-Box annotation

---

Distance to TSS:	-100
Nearest PromoterID:	NR_135840
Entrez ID:	105376114
Nearest Unigene:	Hs.9589
Nearest Refseq:	NR_135839
Nearest Ensembl:	ENSG00000254473
Gene Name:	LOC105376114
Gene Alias:	-
Gene Description:	uncharacterized LOC105376114
Gene Type:	ncRNA
CpG%:	0.075
GC%:	0.557214
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBQLN1 p2@UBQLN1 p3@UBQLN1 p4@UBQLN1 p7@UBQLN1 p9@UBQLN1
Sample		p1@UBQLN1	p2@UBQLN1	p3@UBQLN1	p4@UBQLN1	p7@UBQLN1	p9@UBQLN1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	25.71	2.14	7.40	0.97	0.78	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	29.74	1.82	5.87	1.01	1.42	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	25.27	4.63	5.59	0.77	0.77	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	23.29	3.95	7.69	1.04	0.62	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	27.22	3.37	6.52	1.12	0.90	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	26.94	3.29	4.65	1.36	0.78	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	37.26	3.92	5.88	2.40	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	31.97	3.15	4.12	3.15	1.70	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	31.42	4.92	5.77	1.07	1.07	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	31.30	4.64	6.96	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	35.57	3.64	8.08	1.62	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	42.69	5.29	11.79	1.63	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.98	6.77	0.48	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	23.15	7.67	0.90	0.90	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	24.59	6.59	1.32	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.39	7.29	0.50	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.00	4.59	0.87	1.09	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.34	5.91	0.42	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	17.06	5.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	18.81	8.88	0.90	0.45	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	23.92	5.21	0.40	0.27	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	21.58	7.42	0.52	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	27.01	7.50	0.78	0.26	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	24.02	8.98	0.49	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	23.48	8.51	0.77	1.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	17.72	6.96	0.63	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.69	8.79	0.55	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	23.10	9.90	0.94	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	23.26	7.59	0.32	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	22.98	7.78	1.45	0.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	19.05	9.00	0.84	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	21.49	9.96	1.56	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	21.31	9.50	0.21	0.42	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	15.83	9.40	0.82	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.56	11.03	2.06	0.75	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	30.28	10.16	1.53	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	25.34	8.79	1.23	0.82	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.16	8.66	2.42	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	24.58	11.61	1.08	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	28.33	12.00	1.68	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	26.58	8.47	1.18	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	18.30	7.76	2.05	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	28.89	10.97	0.63	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.27	10.66	1.22	1.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	26.90	9.44	0.40	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	30.94	11.17	1.16	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	28.07	8.64	1.20	0.72	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	24.74	8.94	2.38	0.00	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	30.16	9.10	2.15	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	24.67	12.13	1.42	0.61	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.63	7.99	0.61	0.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	24.24	8.45	2.67	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	28.39	8.16	3.19	1.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	22.53	9.94	0.99	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	7.55	7.55	1.68	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	12.40	6.43	0.46	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	27.23	7.13	2.27	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	36.93	7.71	2.25	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	15.72	7.86	1.26	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	30.32	7.76	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.36	9.53	2.80	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.13	5.57	1.59	1.59	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.17	5.78	1.02	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.52	10.72	2.60	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.88	3.19	1.42	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	36.56	8.78	2.44	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	41.16	9.92	1.98	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	33.31	7.51	2.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	23.18	8.94	0.66	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	48.26	14.23	4.02	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	42.19	16.20	2.45	0.61	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	34.84	8.55	4.43	0.48	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	37.22	6.42	5.94	0.32	2.09	0.00
Adipocyte - omental, donor1	11473-119C6	35.24	9.03	4.45	0.64	0.38	0.38
Adipocyte - omental, donor2	11474-119C7	21.68	4.48	3.74	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	20.76	3.68	2.34	0.00	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	18.50	5.74	1.28	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	20.89	1.10	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	17.61	3.61	0.90	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	23.46	3.48	1.74	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	57.89	9.78	2.74	0.20	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	30.37	6.95	0.77	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	42.65	7.53	1.95	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	28.80	9.99	0.00	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	73.76	7.24	6.60	1.45	4.02	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	31.95	5.16	1.94	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	29.33	5.33	2.67	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	49.52	6.68	5.56	0.56	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	45.33	10.40	8.73	1.25	4.57	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	39.94	4.27	4.02	0.00	1.51	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	48.76	5.56	9.49	0.65	3.27	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	50.85	10.96	4.87	0.91	5.18	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	23.43	2.21	1.10	0.66	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	10.76	0.72	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	19.43	1.98	0.54	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	17.05	1.85	0.82	0.21	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	20.14	2.86	0.69	0.23	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	17.88	5.14	0.49	0.24	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	22.46	5.39	2.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	18.67	5.21	2.17	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	12.84	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.94	4.48	3.29	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	6.32	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	17.82	6.60	1.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.17	4.87	1.62	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.76	3.40	2.43	0.49	0.49	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.25	5.34	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	17.70	4.90	2.64	0.75	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.04	10.89	2.90	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	20.06	6.27	3.76	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.18	7.91	2.31	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	21.84	4.09	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	20.06	7.09	2.11	0.15	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	21.97	4.82	3.21	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	25.13	6.99	3.21	0.38	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	18.44	10.42	2.41	0.00	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	16.58	5.85	2.93	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	23.88	6.63	1.00	0.50	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	6.00	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	7.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	29.67	5.32	3.43	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	16.78	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.87	4.85	3.40	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	20.49	7.97	3.42	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	16.96	2.42	2.42	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.96	5.13	1.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	22.87	7.70	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	17.55	6.71	1.55	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	17.36	5.63	1.41	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	24.12	7.72	3.22	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	5.71	3.57	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.13	4.68	2.34	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.67	6.02	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	7.13	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	3.05	2.03	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	23.94	3.31	2.29	0.25	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.88	5.08	1.91	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	20.28	6.90	1.29	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	21.17	5.93	1.69	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	16.82	5.22	1.74	0.29	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	27.40	8.50	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	20.17	5.76	2.54	0.17	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	27.46	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.44	6.43	2.79	0.00	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.85	10.23	1.80	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	20.41	6.56	2.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	20.92	7.82	1.61	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	12.75	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.05	9.41	1.53	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	26.22	8.05	2.48	0.62	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	18.36	9.18	0.61	0.31	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	20.55	7.65	3.35	0.48	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.74	10.20	3.33	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	4.58	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	21.60	4.43	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	30.98	9.27	3.71	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.26	8.72	2.91	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	20.63	0.25	0.00	0.74	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	22.25	0.86	1.03	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	12.58	0.00	0.42	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	32.77	3.49	0.35	2.44	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	46.59	4.04	1.62	1.78	0.49	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	45.79	3.43	1.64	2.09	0.45	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	91.06	2.52	6.77	1.15	0.00	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	92.33	4.38	8.77	1.13	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	82.84	1.93	6.15	0.80	0.11	0.11
Basophils, donor1	12241-129G9	62.24	13.08	20.66	0.26	0.26	1.31
Basophils, donor2	12242-129H1	72.16	27.42	35.72	0.36	0.00	2.53
Basophils, donor3	12243-129H2	82.76	15.14	17.35	0.44	0.29	1.91
Bronchial Epithelial Cell, donor1	11511-119G8	12.29	1.51	0.00	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	0.91	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	13.81	6.28	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	16.64	2.91	1.25	0.21	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	19.11	4.38	0.23	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	29.15	5.40	0.54	1.26	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	75.64	2.06	18.96	0.93	0.00	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	79.42	1.86	7.92	0.93	0.47	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	63.00	3.84	18.55	0.64	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	0.00	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	43.96	30.43	11.27	0.00	0.00	2.25
CD14+ Monocytes, donor2	11305-117B9	74.05	43.99	32.11	0.19	0.19	1.30
CD14+ Monocytes, donor3	11381-118B4	59.49	32.05	25.91	0.00	0.44	2.20
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	60.01	6.23	7.08	0.85	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	73.16	4.17	5.31	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	102.90	4.27	5.59	0.99	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	64.47	14.60	13.59	0.14	0.00	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	60.35	18.10	13.88	0.60	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	69.88	16.11	18.71	0.24	0.00	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	55.41	22.60	12.22	0.67	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	58.51	20.98	15.46	0.28	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	62.48	28.02	20.08	0.25	0.00	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	47.38	27.80	10.57	0.00	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	55.73	24.21	13.35	0.36	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	62.68	26.55	14.15	0.44	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	49.87	21.54	16.39	0.47	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	46.99	21.65	15.84	1.06	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	44.37	13.31	28.84	1.11	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	60.54	20.08	13.68	0.00	0.15	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	60.46	18.76	14.17	0.80	0.20	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	57.25	14.99	12.08	0.21	0.42	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	54.68	25.40	14.87	0.00	0.00	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	48.86	22.39	15.83	0.45	0.23	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	52.38	20.95	9.17	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	64.29	17.22	18.02	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	70.66	21.11	13.43	0.35	0.17	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	81.22	20.20	17.25	0.00	0.42	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	41.89	36.93	9.74	0.37	0.37	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	57.77	32.06	11.27	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	62.30	33.34	14.48	0.44	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	46.03	24.94	9.59	0.00	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	52.78	17.10	10.41	0.74	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	58.20	27.81	11.42	0.22	0.43	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	36.44	18.02	9.83	0.41	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	47.52	23.18	10.43	0.00	0.00	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	50.34	28.30	10.44	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	47.52	2.40	6.32	0.44	0.00	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	49.66	4.85	3.93	0.23	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	52.20	2.60	4.98	0.43	0.00	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	73.81	8.88	8.72	0.31	0.00	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	56.76	7.68	6.99	0.35	0.00	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	80.49	6.69	8.92	0.00	0.22	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	58.43	1.53	6.38	0.26	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	55.99	3.73	4.39	0.66	0.00	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	63.58	2.11	6.53	0.63	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	54.87	0.00	20.32	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	88.82	1.36	12.88	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	67.31	2.07	5.18	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	108.74	0.53	13.33	0.00	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	91.13	2.14	8.04	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	81.42	1.40	14.74	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	66.67	1.57	7.84	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	73.82	1.32	11.86	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	130.68	4.93	46.85	1.64	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	113.17	12.33	36.27	1.45	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	106.52	7.07	36.85	1.01	0.00	2.52
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	83.24	10.10	4.44	5.25	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	52.33	5.99	1.60	2.40	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	71.29	6.02	27.11	0.00	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	59.55	19.66	34.27	1.12	0.00	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	69.14	0.75	8.27	0.75	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	49.61	2.48	9.92	1.35	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	207.45	13.93	73.91	1.43	1.07	5.36
CD4+ T Cells, donor2	11306-117C1	150.64	14.08	106.55	1.22	0.00	4.29
CD4+ T Cells, donor3	11382-118B5	140.30	13.42	85.40	0.91	0.30	2.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	79.38	0.77	9.70	0.26	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	87.82	1.57	8.53	0.67	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	93.71	1.72	7.47	0.57	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	128.95	5.69	29.39	0.47	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	102.54	2.11	25.28	0.00	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	174.70	0.00	32.96	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	67.49	1.45	12.14	0.43	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	77.11	2.54	14.57	0.34	0.17	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	70.93	1.77	10.80	0.16	0.00	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	87.87	1.79	36.31	0.00	0.00	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	87.35	4.89	24.46	0.00	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	102.52	4.40	35.64	0.00	0.00	3.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	82.64	1.69	13.91	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	66.69	1.25	9.77	0.42	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	59.47	1.00	15.04	1.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	138.96	4.35	31.82	0.54	0.00	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	153.28	4.29	24.65	0.54	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	139.87	5.38	28.69	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	96.42	1.30	17.06	0.00	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	72.35	1.73	14.95	0.00	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	83.01	1.47	18.49	0.63	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	98.59	5.06	29.83	0.51	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	92.28	4.33	30.33	0.43	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	112.00	1.74	37.92	0.44	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	114.81	3.96	17.82	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	87.70	0.00	11.08	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	99.10	1.40	13.96	0.00	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	102.19	3.32	16.89	0.83	0.00	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	111.65	5.15	19.63	0.25	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	138.60	6.16	27.72	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	111.37	2.15	16.12	0.72	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	94.18	4.15	20.77	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	121.79	12.44	63.19	1.31	0.00	2.62
CD8+ T Cells, donor2	11307-117C2	100.24	20.65	102.87	0.00	0.38	6.38
CD8+ T Cells, donor3	11383-118B6	143.16	12.37	82.31	0.76	1.01	4.54
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	20.87	3.21	3.44	0.92	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	25.40	1.92	3.12	0.96	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	27.09	1.37	2.19	0.27	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	21.92	2.10	3.30	0.30	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	27.12	3.36	4.56	0.96	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.01	4.78	2.05	0.68	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	30.64	2.61	3.04	1.09	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	25.27	2.63	2.63	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	30.02	1.17	3.28	1.64	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	25.06	1.51	3.62	1.81	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	24.69	2.32	2.91	1.16	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	28.51	1.60	5.06	1.33	1.07	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	35.02	4.82	9.63	1.31	6.57	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	33.25	4.55	13.66	0.91	8.65	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.77	7.46	5.97	0.00	5.97	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	25.21	3.60	6.12	0.00	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	25.89	5.18	3.45	1.15	0.58	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.75	4.48	3.77	0.94	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.32	2.54	4.12	1.58	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	31.06	2.77	2.46	1.54	1.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	29.81	1.92	2.56	0.64	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	29.45	2.68	4.21	2.29	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	29.56	4.34	5.12	0.39	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	29.50	3.78	6.05	0.00	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	48.18	4.82	9.64	2.41	8.03	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	43.36	3.50	6.99	1.40	7.69	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	43.08	3.01	8.01	0.00	9.02	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	21.74	0.00	0.49	0.99	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	37.78	1.89	1.26	0.21	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	25.31	4.85	1.73	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	18.83	4.62	1.42	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	24.92	9.10	1.59	0.23	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	20.59	4.48	2.69	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	21.03	8.90	2.02	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	40.62	4.36	1.26	1.26	0.11	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	39.55	2.57	0.86	0.86	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	43.36	3.72	2.30	1.86	0.53	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	49.15	6.24	3.58	3.58	0.09	0.09
Corneal Epithelial Cells, donor1	11526-119I5	10.54	0.88	0.22	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	10.24	2.28	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.10	2.30	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	57.95	2.31	7.92	0.17	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	55.20	2.21	5.68	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	3.45	6.90	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	46.98	3.24	4.64	0.32	0.00	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	81.31	2.39	9.91	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	69.86	5.22	13.71	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	54.69	1.94	12.10	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	41.53	4.00	4.50	0.33	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	31.69	3.52	1.76	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	38.74	3.39	6.79	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	40.10	7.08	10.22	0.79	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	34.61	2.62	8.44	1.16	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	45.64	6.82	8.71	0.24	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	39.62	4.38	6.14	0.18	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	43.22	3.32	7.98	0.00	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	60.24	3.35	10.04	0.91	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	72.45	5.07	19.17	0.28	0.00	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	31.79	3.86	5.65	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	19.79	3.12	5.21	0.00	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	34.31	1.56	8.65	0.14	0.43	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	63.62	8.00	13.20	0.40	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	32.50	1.05	4.19	0.52	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	74.18	5.47	10.19	0.75	0.37	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	53.66	5.87	10.43	0.22	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	58.87	5.86	9.04	0.61	0.37	0.24
Endothelial Cells - Vein, donor1	11267-116G7	34.13	3.41	4.55	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	33.53	6.29	6.29	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	42.55	3.77	7.54	0.79	0.16	0.47
Eosinophils, donor1	12244-129H3	106.73	0.00	45.74	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	212.88	37.96	70.96	1.65	0.00	4.95
Eosinophils, donor3	12246-129H5	135.54	32.10	49.94	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.97	0.73	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	26.27	13.14	1.64	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.70	7.23	2.63	0.11	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	19.83	6.72	1.08	0.11	0.00	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	34.81	7.28	2.30	0.49	0.12	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	48.99	11.60	4.23	0.82	0.00	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	29.00	6.75	1.69	0.11	0.00	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	29.51	5.27	1.84	1.05	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	34.55	5.32	1.33	0.66	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	29.03	5.44	2.72	1.36	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	34.87	3.79	2.27	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	23.50	4.89	2.52	0.32	0.00	0.32
Fibroblast - Cardiac, donor4	11452-119A3	44.56	3.03	0.61	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	34.39	5.46	2.54	0.13	0.00	0.13
Fibroblast - Cardiac, donor6	11460-119B2	38.66	3.94	3.79	0.30	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	24.25	1.88	1.34	0.13	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.00	3.02	1.73	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	1.46	0.00	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	27.91	1.38	0.69	0.69	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	23.41	3.05	0.68	1.02	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	23.71	7.98	1.41	0.47	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	22.17	5.19	2.83	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	26.35	14.02	0.97	0.60	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	36.06	6.44	0.57	0.57	0.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	29.66	7.68	2.27	0.52	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	39.31	7.80	0.97	0.49	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	36.65	6.04	0.62	0.21	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	36.16	13.62	2.10	0.52	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	29.52	5.93	1.05	0.53	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	32.49	5.90	1.26	0.39	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	5.19	4.16	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	32.07	7.05	1.23	0.35	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	42.09	11.07	2.18	0.78	0.31	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	32.73	11.63	2.30	0.81	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	37.76	7.06	2.82	0.71	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	32.91	15.21	2.19	0.73	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	36.68	14.45	2.05	0.82	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	35.76	14.37	2.52	1.21	0.11	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	26.71	9.98	0.73	0.29	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	10.87	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	38.80	10.45	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	32.50	4.43	1.27	0.63	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	20.83	0.00	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	1.40	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.92	1.96	0.84	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	41.00	3.25	3.25	1.22	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	37.44	5.04	0.97	0.78	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	47.17	5.61	1.97	1.67	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	74.05	7.04	2.14	0.92	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.35	5.34	0.76	1.14	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	29.16	11.34	1.89	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	33.52	9.63	1.86	0.35	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	36.03	3.87	2.54	0.44	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	33.32	1.42	0.20	0.81	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	0.67	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	22.14	1.98	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	39.29	11.11	2.38	0.40	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	27.00	5.68	0.36	0.71	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	33.11	7.69	1.77	0.20	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.68	5.42	4.21	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	30.98	9.28	1.40	0.54	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	42.26	8.86	3.80	1.27	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	33.31	6.07	1.64	0.16	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	50.33	9.02	2.81	1.40	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	33.05	12.46	2.11	0.20	0.20	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	46.54	11.49	2.42	0.60	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	28.33	9.94	0.75	0.91	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	26.33	6.84	0.17	0.17	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	26.27	6.90	1.64	0.66	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	33.55	10.12	2.24	0.21	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	37.28	4.89	2.02	0.34	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.39	5.96	0.47	0.16	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	33.99	19.17	2.61	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	43.51	10.75	4.33	0.69	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	51.79	11.97	2.60	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	59.53	13.29	4.09	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	45.17	4.59	5.36	1.53	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	50.41	1.28	9.57	1.91	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	61.05	3.42	6.28	2.00	2.00	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	98.17	22.61	1.65	3.58	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	64.39	5.71	3.42	2.28	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	72.52	3.57	3.96	2.38	0.99	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	84.06	19.83	2.64	4.23	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	60.99	9.13	5.54	4.57	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	47.32	4.86	7.52	1.33	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	57.24	2.97	3.39	1.84	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	54.80	2.83	3.45	3.20	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	62.86	2.69	4.84	0.81	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	50.30	3.47	2.48	2.23	0.62	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	51.22	3.05	2.91	2.08	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	44.12	3.46	2.24	2.24	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	54.08	2.28	2.28	1.14	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	49.33	3.74	2.24	2.37	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	53.55	3.72	2.40	1.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	49.64	1.48	3.25	1.18	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	51.82	2.54	2.70	1.59	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	51.39	3.35	2.90	1.56	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	53.43	1.61	2.42	0.81	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	55.64	3.05	3.73	1.70	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	68.72	3.37	4.34	1.24	0.35	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	65.14	1.77	2.60	0.52	0.10	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	59.60	1.20	3.93	0.34	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	48.02	2.77	2.88	1.88	0.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	61.23	3.41	4.08	1.16	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	53.90	2.45	4.08	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	47.86	2.48	1.86	0.62	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	56.61	2.77	3.69	1.50	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	54.03	3.00	6.00	0.67	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	48.72	2.42	2.65	1.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	56.33	2.34	3.57	1.72	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	51.55	2.76	4.38	0.65	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	50.35	1.28	3.21	1.28	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	43.78	2.37	3.88	0.76	0.47	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	51.25	2.85	3.01	0.95	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	50.17	4.26	3.04	0.00	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	43.80	3.76	4.18	1.15	0.52	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	48.52	2.85	3.73	0.88	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	48.82	1.96	2.24	1.68	0.28	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	40.65	2.87	2.41	0.46	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	44.92	4.01	5.35	0.53	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	60.90	3.83	7.34	1.07	0.77	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	38.08	3.89	4.27	0.91	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	54.49	2.98	3.52	1.08	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	45.53	4.06	3.69	0.92	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	41.23	1.97	2.41	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	59.50	3.97	3.97	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	44.72	2.77	3.30	0.26	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.94	5.45	2.42	0.20	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	56.93	3.05	4.32	1.78	0.00	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	67.28	2.99	5.97	1.79	1.19	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	58.24	2.62	3.24	3.39	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	63.22	2.45	3.48	3.68	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	59.14	2.19	3.13	1.25	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	48.88	0.57	1.98	0.28	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	73.33	11.07	6.46	0.46	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	4.95	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	51.45	1.93	3.48	2.32	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	57.76	6.42	4.81	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	53.90	0.00	6.96	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	51.10	2.93	4.23	1.95	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	53.95	2.06	5.35	1.65	0.82	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	10.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	48.10	3.08	3.64	1.40	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	54.91	1.63	3.92	1.63	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	40.26	0.84	2.52	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	52.16	1.91	3.18	0.64	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	47.89	2.38	0.68	1.02	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	62.64	0.00	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	44.67	2.86	2.86	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	34.63	0.59	2.37	0.30	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	40.66	3.39	3.39	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	57.57	0.83	3.73	0.83	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	53.39	1.84	4.37	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	5.27	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	41.90	1.92	2.31	0.77	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	26.73	3.59	2.93	0.33	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	44.14	2.68	3.34	0.67	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	41.99	3.47	2.70	1.54	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	63.68	3.77	10.27	1.03	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	46.71	0.94	2.83	2.36	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	43.45	2.41	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	50.87	2.54	1.02	1.53	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	43.87	4.39	2.39	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	48.35	2.47	2.96	0.99	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	46.04	1.18	5.90	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	41.42	7.00	1.17	1.75	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	52.23	2.63	1.32	2.63	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.01	0.85	3.39	1.70	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	39.99	3.58	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	32.03	2.43	2.91	0.00	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	20.54	2.28	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	21.62	3.74	1.25	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	25.86	3.37	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	30.13	4.44	2.54	0.32	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.77	3.34	1.67	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	42.24	7.31	4.64	1.16	0.58	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	44.90	5.57	4.22	0.84	0.51	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	49.14	5.46	4.78	1.37	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	43.29	6.23	6.01	1.86	0.55	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	47.71	8.81	8.17	1.07	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	42.63	4.74	4.74	0.86	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	45.33	6.60	5.36	0.87	0.50	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	40.14	5.15	6.18	1.20	0.34	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	36.20	5.45	5.45	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	29.10	1.12	6.16	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	17.31	0.43	3.03	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	2.64	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	22.22	0.35	1.41	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	0.73	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	34.79	3.67	2.97	0.17	0.00	0.00
Hepatocyte, donor1	11523-119I2	48.42	6.05	9.68	1.21	1.21	0.00
Hepatocyte, donor2	11603-120I1	62.49	10.77	7.54	1.08	1.08	1.08
Hepatocyte, donor3	11684-122I1	60.13	4.91	9.20	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	63.31	0.00	17.62	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	31.99	1.92	3.15	1.05	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	33.75	3.57	1.23	0.82	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	1.38	4.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	0.00	5.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	4.57	0.00	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	42.23	3.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	1.67	1.67	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	26.47	1.32	5.29	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	22.17	1.11	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.12	1.26	1.26	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	17.44	0.65	1.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	12.88	0.00	3.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	15.48	1.63	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	27.29	0.84	1.26	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	18.48	0.80	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	20.31	1.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	18.41	1.89	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	0.00	0.91	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	26.90	2.15	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	0.00	2.54	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.13	0.64	1.28	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	22.85	1.43	1.43	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	19.14	0.93	1.23	1.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	1.76	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.99	0.00	0.70	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	0.00	2.21	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	13.87	2.13	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	2.85	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.97	0.92	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	1.06	2.11	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	27.83	9.96	1.06	0.16	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	16.40	2.93	1.76	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	41.46	8.52	1.04	0.47	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	48.24	9.65	0.57	0.57	0.00	0.00
Keratocytes, donor1	11527-119I6	27.16	1.72	1.03	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	7.03	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	25.29	1.78	0.00	0.79	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	4.40	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	31.28	1.08	2.16	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	43.13	2.42	1.27	0.92	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	58.22	8.07	3.63	0.50	0.10	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	55.26	4.51	9.37	0.12	0.59	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	32.09	3.35	7.26	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	54.78	4.56	11.02	0.16	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	42.48	4.30	10.22	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	34.67	1.89	7.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	26.74	2.37	6.36	0.00	0.11	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	47.61	5.34	9.44	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.52	1.52	5.06	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	35.19	2.96	7.32	0.42	0.28	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	41.93	2.77	9.10	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	36.64	4.46	8.14	0.39	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.59	1.11	4.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	45.99	2.44	7.67	0.00	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	39.59	2.62	7.16	0.24	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	28.02	3.43	6.59	0.00	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	44.96	2.46	8.93	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	20.58	2.49	4.68	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	32.21	2.20	7.50	0.18	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	42.78	4.28	10.86	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	27.82	4.10	5.56	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	24.89	2.74	3.98	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	43.65	6.79	5.82	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	42.28	3.50	4.85	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	38.75	2.42	8.48	0.00	0.15	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	35.25	2.07	3.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	47.11	5.44	10.26	0.21	0.21	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	35.19	3.16	8.72	0.00	0.15	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	38.52	6.19	11.69	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	44.03	3.39	7.15	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	26.93	3.07	5.83	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	40.22	4.36	10.66	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	38.04	3.97	6.62	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	27.75	1.49	7.19	0.00	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	56.27	5.92	12.59	0.00	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	34.84	4.20	7.91	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	25.30	2.34	5.77	0.00	0.55	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	48.25	6.43	8.04	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	44.43	4.26	11.26	0.00	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	44.09	5.04	10.36	0.28	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	39.11	7.11	8.18	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	28.60	2.91	6.79	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	21.79	1.24	4.51	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	37.60	3.58	7.52	0.00	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	44.43	4.57	5.88	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	18.36	0.94	4.47	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	57.42	3.09	7.92	0.25	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	25.87	2.05	4.10	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.96	1.79	6.56	0.30	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	0.00	9.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	38.36	1.53	5.37	1.53	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	34.88	3.71	7.42	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	35.54	1.69	8.04	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	37.28	0.00	4.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	29.89	1.87	6.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	14.43	4.64	2.58	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	14.27	0.00	3.57	0.00	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	35.51	2.49	4.07	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	35.19	2.91	5.23	0.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	38.72	3.60	4.95	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	45.79	3.93	6.64	0.95	0.14	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	32.35	3.08	4.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	38.46	3.18	6.35	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	30.65	3.33	4.00	2.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	46.35	2.55	6.62	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	41.89	3.20	6.40	1.07	0.53	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	41.57	5.48	7.94	0.57	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	36.20	3.07	8.59	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	48.93	4.08	5.71	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	40.40	3.54	7.50	0.00	0.42	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	39.80	1.96	5.61	0.56	0.56	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	39.15	3.09	4.12	0.00	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	45.87	3.19	8.13	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	34.38	2.39	7.17	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	39.83	3.32	6.64	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	48.43	2.12	8.13	1.06	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	44.62	3.32	5.90	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	28.78	3.45	5.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	34.15	1.54	6.52	1.92	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	39.63	5.10	8.49	0.57	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	41.84	1.64	9.03	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	39.31	3.16	8.59	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	40.22	4.31	5.03	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	59.75	3.73	10.46	1.49	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	41.99	3.34	3.34	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	44.80	3.02	4.74	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	39.39	1.71	6.85	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	41.31	3.66	8.66	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	48.26	4.83	7.24	1.21	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	45.50	1.42	10.66	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	47.78	3.78	5.50	0.69	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	47.77	4.83	5.37	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	47.14	2.02	4.71	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	37.41	4.07	5.93	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	40.70	3.49	8.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	28.56	1.06	6.35	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	39.21	2.00	7.20	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	33.44	5.09	7.27	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	51.36	5.37	9.20	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	38.97	0.99	5.92	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	28.23	3.76	10.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	38.72	3.52	2.01	1.51	1.51	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	33.80	3.60	5.86	0.90	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	8.61	3.44	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	36.96	4.45	5.79	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	43.79	2.74	12.90	1.56	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.99	3.96	6.60	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	52.41	1.56	8.30	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	47.69	5.69	9.19	0.44	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	49.20	3.35	10.62	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	54.32	2.65	6.62	1.32	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	43.97	3.86	5.40	1.16	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	27.85	4.05	4.56	2.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	42.29	2.88	9.13	0.96	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	41.74	2.78	7.55	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	38.89	3.04	10.94	1.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.06	2.08	5.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	42.56	6.84	7.22	1.14	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	33.05	4.65	6.20	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	27.81	3.63	5.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	42.15	3.17	5.70	0.32	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	34.65	5.33	5.33	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.84	2.30	8.62	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	49.37	2.06	9.26	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	43.86	4.24	6.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	25.54	2.84	5.11	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	48.26	1.25	7.07	0.83	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	54.03	0.78	4.70	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	32.57	2.92	8.35	2.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	46.46	4.65	5.58	0.93	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	38.80	2.68	4.68	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	38.49	4.81	7.48	2.14	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	52.13	3.64	7.68	1.21	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	33.04	1.84	6.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	35.56	4.45	5.33	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	57.56	5.13	4.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	39.88	4.60	5.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	33.38	4.92	7.11	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	53.45	4.01	5.35	0.89	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	54.85	3.38	6.76	2.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	39.79	5.30	5.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	60.28	2.08	4.16	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	45.58	1.37	2.28	0.46	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	58.72	3.30	2.39	0.37	0.00	0.55
Macrophage - monocyte derived, donor3	11389-118C3	44.96	3.28	3.67	0.26	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	36.64	6.90	2.12	0.53	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	26.78	12.36	2.06	0.32	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	34.61	10.70	2.50	0.42	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	48.83	17.54	2.49	0.50	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	39.09	12.74	2.03	0.58	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	22.70	3.24	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	46.10	8.81	8.81	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	60.78	4.11	5.19	0.32	0.00	0.22
Mast cell, donor2	11565-120D8	91.23	18.72	10.70	0.89	0.30	1.19
Mast cell, donor3	11566-120D9	111.89	21.84	9.91	1.58	0.23	0.23
Mast cell, donor4	11567-120E1	102.83	20.03	10.11	0.53	0.00	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	56.11	6.88	5.99	0.22	0.00	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	70.04	11.09	7.59	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	54.26	5.28	6.88	0.57	0.23	0.00
Mast cell, expanded, donor8	11941-126A6	65.27	8.54	12.89	0.33	0.17	0.50
Melanocyte - dark, donor1	11502-119F8	60.10	3.28	15.32	0.30	0.80	0.50
Melanocyte - dark, donor2	11582-120F7	25.26	0.69	3.46	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	72.66	4.49	3.40	0.94	0.22	0.22
Melanocyte - light, donor1	11274-116H5	46.31	3.53	2.82	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	36.85	0.68	3.41	0.68	0.68	1.36
Melanocyte - light, donor3	11423-118G1	25.15	0.87	0.87	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	46.65	2.71	2.08	0.42	0.62	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	61.32	3.77	4.84	0.54	1.34	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	60.80	1.61	6.43	0.80	0.54	0.80
Meningeal Cells, donor1	11493-119E8	39.70	1.12	0.99	0.74	0.12	0.12
Meningeal Cells, donor2	11573-120E7	35.65	2.20	1.32	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	49.96	4.16	1.87	0.82	0.00	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	33.08	3.71	0.57	1.43	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	27.98	9.26	2.52	0.70	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	28.70	9.33	3.59	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	29.65	4.87	0.85	0.21	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	32.17	6.03	1.51	0.00	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	20.44	0.88	0.44	1.10	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.00	0.73	2.92	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.98	1.64	1.02	0.41	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.16	6.09	1.11	0.42	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.66	0.37	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	31.18	5.39	0.66	0.39	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	12.46	1.48	0.89	0.59	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.29	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	40.05	7.09	2.13	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	24.08	4.38	1.25	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	42.82	2.90	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	33.15	12.46	2.65	0.53	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	23.52	11.51	3.00	0.00	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	33.10	9.76	2.67	0.36	0.14	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	25.66	5.40	5.40	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	54.18	3.20	5.91	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	49.17	3.24	3.53	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	38.03	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	34.09	2.48	4.03	0.93	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	37.75	2.70	2.70	0.83	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	6.95	4.63	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	42.04	3.25	3.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	41.89	4.65	6.05	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	34.55	3.25	3.25	0.41	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	43.16	3.56	3.56	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	17.70	4.42	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	36.09	3.04	2.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	21.05	3.95	6.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	26.74	2.55	3.18	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	19.34	2.76	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	24.44	5.37	3.87	0.30	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	1.68	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	26.60	3.26	2.51	0.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	27.09	2.85	2.38	0.48	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	22.67	1.66	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	24.64	4.37	3.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	35.13	3.58	2.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	30.57	3.06	1.83	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.81	3.65	3.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	31.12	4.67	3.78	0.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	18.40	5.04	1.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	22.81	1.52	4.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	23.20	3.31	1.66	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.10	5.71	4.89	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	34.70	5.29	6.18	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	17.45	7.63	3.27	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	21.62	4.32	3.36	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	29.22	4.80	4.00	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	6.86	4.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	32.04	3.50	1.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	4.08	8.15	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	35.47	6.13	3.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	20.97	6.62	6.62	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	25.62	7.68	2.56	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	31.98	11.16	5.45	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	14.61	3.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	26.52	6.63	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	33.16	5.47	4.10	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	34.57	6.56	7.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	22.73	6.04	3.91	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	30.30	5.05	3.09	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	32.42	4.99	3.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	22.73	7.58	2.33	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	38.01	6.03	5.43	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	32.14	4.17	3.34	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	29.55	6.46	2.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	51.79	10.24	5.12	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	31.51	7.32	3.73	0.28	0.00	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	35.50	6.48	4.66	0.26	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	43.33	7.72	6.01	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	33.67	5.72	3.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	45.37	4.54	4.80	0.00	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	54.48	11.37	4.19	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	28.67	5.65	3.25	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	40.13	6.05	4.78	0.64	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	49.75	6.63	4.42	0.44	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	42.85	7.96	4.55	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	43.75	6.82	5.40	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	53.34	6.88	4.92	0.25	0.00	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	23.46	5.21	5.21	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	46.75	6.47	4.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	47.57	8.07	6.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	49.05	8.66	5.36	0.41	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	40.50	8.64	3.57	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	5.35	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	42.71	2.30	4.27	0.33	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	38.92	1.05	4.21	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	34.40	2.17	4.35	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	61.47	0.93	2.79	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	37.55	1.88	3.76	0.38	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	39.95	2.93	4.26	1.07	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	31.10	1.70	2.38	0.34	0.11	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.05	2.21	0.74	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	36.28	2.20	4.40	0.37	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	52.89	1.56	3.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	20.84	0.53	2.14	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	24.24	1.01	5.05	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.50	2.11	1.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	21.79	5.45	4.09	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.36	1.91	2.54	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.10	1.62	0.81	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	4.53	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	11.42	22.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	3.26	29.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	12.55	0.00	12.55	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	36.62	3.66	2.80	0.22	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	21.95	2.61	1.57	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	32.71	7.34	2.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	28.80	16.28	3.34	0.00	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	18.63	14.45	1.52	0.76	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	30.32	7.98	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.76	12.92	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	5.51	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	29.30	7.12	1.26	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.31	12.55	3.02	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	28.10	5.94	2.43	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	32.59	7.36	1.89	0.00	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	20.35	5.46	3.47	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	15.97	7.04	1.08	0.00	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	25.62	10.43	2.04	0.00	0.00	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	26.62	8.82	2.12	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	25.33	4.56	1.64	0.36	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	22.81	10.61	1.06	0.53	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	21.61	11.41	3.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	13.46	10.17	0.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	26.35	10.25	3.09	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.40	7.41	1.59	0.35	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	23.91	5.63	2.11	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.39	14.25	1.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	29.89	10.28	1.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.14	12.76	2.07	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	25.40	6.68	2.01	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.44	8.89	0.85	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	13.53	8.54	1.42	0.24	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	35.20	9.01	4.72	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	18.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	29.66	6.66	2.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	24.35	6.31	1.35	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	18.65	3.97	3.57	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	25.07	5.57	4.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.43	7.95	1.14	1.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.16	6.84	5.21	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	29.20	9.15	2.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	25.78	6.78	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	20.28	6.17	6.17	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.95	8.64	0.66	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	38.69	6.94	2.48	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.74	6.13	2.30	0.38	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	27.22	4.54	0.91	1.21	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	20.78	9.95	1.77	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	26.43	6.78	6.10	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	31.70	6.71	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.51	6.29	1.89	0.94	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.30	3.33	0.91	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	25.32	3.16	1.58	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	10.20	6.80	1.13	0.00	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	30.31	11.30	3.23	0.25	0.12	0.00
Myoblast, donor2	11322-117D8	41.43	11.51	3.64	0.00	0.38	0.00
Myoblast, donor3	11398-118D3	43.72	9.92	2.35	0.84	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	47.14	1.31	5.25	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	99.33	14.45	47.05	0.31	0.62	3.69
Natural Killer Cells, donor2	11311-117C6	98.01	18.09	70.56	0.60	0.30	3.02
Natural Killer Cells, donor3	11387-118C1	89.27	13.99	58.16	0.37	0.00	3.50
Neural stem cells, donor1	11275-116H6	58.43	8.71	2.54	1.09	0.00	0.00
Neural stem cells, donor2	11352-117H2	98.21	3.85	11.55	3.85	0.00	0.00
Neurons, donor1	11494-119E9	87.62	12.52	11.38	3.41	1.14	1.14
Neurons, donor2	11574-120E8	68.91	2.42	3.52	1.32	0.00	0.22
Neurons, donor3	11655-122E8	52.62	8.22	9.04	4.11	0.82	0.82
Neutrophils, donor1	11233-116C9	118.78	15.78	19.49	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	98.56	11.60	20.29	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	164.93	23.21	20.77	0.61	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	30.52	4.39	0.59	0.59	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	22.14	1.95	0.65	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	19.25	2.61	0.60	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	20.10	6.33	1.10	0.28	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	24.75	11.15	1.45	0.43	0.29	0.00
Olfactory epithelial cells, donor3	11935-125I9	24.29	7.95	1.36	0.11	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	28.05	9.35	0.78	0.29	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	57.77	6.02	1.81	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	18.08	4.25	0.64	0.43	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	13.72	6.86	2.29	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	14.90	3.10	3.10	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	21.89	5.08	0.20	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	47.76	5.62	0.00	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	33.95	10.66	1.07	0.36	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	29.82	10.70	1.68	0.67	0.00	0.00
Pericytes, donor1	11491-119E6	8.01	0.22	0.11	0.22	0.00	0.00
Pericytes, donor2	11571-120E5	9.05	0.68	0.00	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	14.65	1.83	1.02	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	39.56	3.39	0.79	0.90	0.11	0.00
Perineurial Cells, donor2	11579-120F4	36.34	2.76	2.30	0.64	0.09	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	116.66	6.37	33.15	0.32	0.00	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	91.09	12.73	36.48	0.98	0.24	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	100.56	8.28	40.51	0.52	0.13	1.04
Placental Epithelial Cells, donor1	11278-116H9	11.24	8.37	1.67	0.96	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	9.98	0.00	1.11	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	13.35	4.12	0.59	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	17.09	6.96	2.22	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	32.27	9.00	3.00	0.38	0.00	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	55.47	10.44	3.65	1.17	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	24.77	8.56	2.48	0.00	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	35.16	11.08	2.88	0.43	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	41.90	6.98	3.06	0.87	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	40.11	7.16	3.15	0.29	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	17.72	2.95	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	25.18	5.22	1.84	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	39.49	13.99	2.83	0.89	0.18	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	34.40	11.92	1.36	1.02	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	36.79	15.00	0.84	0.75	0.09	0.09
Preadipocyte - visceral, donor2	11357-117H7	31.75	15.19	0.92	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	27.48	10.55	1.67	0.42	0.10	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	27.91	2.11	1.21	1.06	1.21	0.00
Prostate Epithelial Cells, donor2	11331-117E8	30.87	9.75	4.20	0.27	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	39.01	5.88	1.10	0.61	0.06	0.12
Prostate Stromal Cells, donor1	11254-116F3	34.85	4.67	1.59	0.80	0.00	0.23
Prostate Stromal Cells, donor2	11332-117E9	35.86	5.74	1.79	0.36	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	25.03	5.84	1.15	0.63	0.10	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	20.07	0.36	0.73	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	42.07	6.17	1.04	0.49	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	14.71	0.00	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	12.09	1.42	1.42	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	51.24	5.50	1.59	0.64	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.02	1.36	4.09	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	25.87	0.94	2.96	0.54	0.13	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	49.51	5.11	7.77	0.22	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	17.97	0.00	5.32	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	24.43	1.10	1.32	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	17.56	1.88	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	9.43	0.83	1.39	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	38.92	2.68	1.61	1.07	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	20.66	0.84	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	20.63	1.93	0.77	0.39	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	36.82	1.81	0.52	0.52	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	28.14	0.85	0.85	0.85	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	1.03	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.60	3.26	2.01	1.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	85.79	6.55	10.02	1.47	0.27	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.95	6.25	3.57	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	21.46	5.50	6.05	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	29.00	7.54	5.80	0.00	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	70.34	3.51	6.76	1.17	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	68.42	5.26	7.05	1.09	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	93.47	4.46	5.91	1.78	0.11	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	83.85	6.08	10.42	0.87	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	73.31	4.08	7.23	1.05	0.12	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	74.66	3.24	9.48	0.92	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	60.51	3.01	6.16	1.10	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	64.44	2.72	6.66	1.36	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	92.46	4.30	5.55	2.33	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	63.55	3.01	7.03	1.29	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	67.50	6.01	8.05	1.61	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	73.68	5.97	8.63	1.77	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	52.38	4.40	6.69	1.34	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	71.46	4.66	8.94	0.37	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	82.68	5.07	8.27	1.50	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	69.80	4.64	9.16	0.93	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	76.80	4.28	8.47	1.46	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	71.61	3.63	9.17	1.15	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	61.19	5.02	8.01	1.17	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	68.39	5.33	7.57	0.84	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	83.57	5.64	11.28	0.85	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	60.72	2.37	6.38	0.36	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	68.31	4.78	6.13	0.98	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	79.25	4.84	8.33	1.21	0.13	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	62.51	4.48	8.73	1.18	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	71.43	5.95	8.53	1.98	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	79.51	5.61	11.93	1.40	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	66.15	4.15	9.54	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	69.02	5.75	10.40	2.43	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	75.41	4.80	10.44	1.25	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	75.91	4.44	9.82	1.62	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	73.23	5.62	10.73	1.87	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	81.36	4.43	11.18	2.12	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	76.00	4.30	10.66	0.69	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	82.58	6.45	11.52	2.06	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	86.02	6.24	9.36	0.82	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	57.78	1.53	7.33	0.51	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	70.43	5.03	7.40	1.18	0.15	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	77.83	6.13	8.26	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	48.95	2.35	5.12	0.55	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	65.24	2.86	6.19	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	81.42	4.03	7.26	2.42	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	49.06	1.13	7.06	0.85	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	54.50	2.45	8.38	1.05	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	58.33	3.63	8.76	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	54.46	4.41	7.34	0.73	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	92.72	6.26	6.99	1.46	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	57.19	7.30	5.48	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	53.05	3.01	5.73	1.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	60.39	6.56	7.24	0.90	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	59.61	5.09	6.29	1.20	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	48.29	4.60	6.61	0.71	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	55.07	5.34	4.91	0.85	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	42.67	6.01	5.41	0.60	0.00	0.60
Schwann Cells, donor1	11498-119F4	15.99	0.56	0.38	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	34.02	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	35.49	4.38	2.19	0.22	0.00	0.00
Sebocyte, donor1	11220-116B5	42.18	17.53	2.19	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	36.30	7.81	1.84	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	26.38	5.57	1.24	1.03	0.00	0.00
Sertoli Cells, donor1	11255-116F4	24.85	21.54	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	25.42	19.77	2.82	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	27.63	3.43	0.26	0.79	0.00	0.26
Skeletal Muscle Cells, donor2	11358-117H8	6.51	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	23.41	6.69	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	30.48	5.03	0.79	0.79	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	30.92	3.86	1.49	0.45	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	38.94	5.69	1.39	0.77	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	33.90	5.80	1.51	0.50	0.00	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	29.39	6.42	1.28	0.57	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	48.02	6.05	2.08	1.49	0.20	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.77	2.36	1.10	0.42	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	4.34	0.00	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	14.04	3.16	0.28	0.14	0.00	0.00
Skin - palm, donor1	10286-104F7	26.86	26.86	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	23.93	6.63	3.17	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	43.35	9.81	10.63	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	26.87	4.80	3.64	0.13	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	31.83	9.87	1.81	0.28	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	32.91	10.41	2.67	0.84	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	89.02	10.78	4.23	0.63	0.00	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	47.52	11.02	2.47	1.05	0.07	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.06	11.11	1.23	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.68	14.01	1.56	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	24.10	7.64	1.18	1.18	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.09	5.08	1.77	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	21.66	3.94	2.36	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	29.36	6.18	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	22.02	5.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	28.35	9.18	2.66	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	28.15	9.75	1.33	0.22	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	37.00	17.03	5.51	0.26	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.00	1.63	0.98	1.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	46.07	4.43	1.77	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.46	4.70	2.42	0.43	0.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11.88	0.65	0.33	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	24.96	4.26	0.00	0.91	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	17.93	6.31	0.51	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	22.89	6.20	2.86	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.42	3.54	0.74	0.74	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	25.83	3.87	1.08	0.65	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	34.64	4.51	2.20	0.21	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	25.68	6.19	3.40	0.31	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	8.62	7.55	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	26.30	5.98	2.39	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.70	0.68	1.02	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	30.70	4.55	0.79	0.24	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	31.70	15.90	2.21	1.71	0.00	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	46.42	15.02	3.41	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.30	8.45	2.42	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	60.14	5.56	2.65	2.12	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	35.42	6.92	1.73	0.13	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	29.43	5.01	1.38	1.00	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	18.52	6.60	0.76	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	35.58	8.44	1.51	0.45	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	7.50	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	24.55	2.58	7.75	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	29.30	8.84	1.86	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	32.31	8.58	3.03	1.01	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	26.64	11.91	4.07	0.00	0.00	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.09	0.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	53.32	8.83	1.17	1.25	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.03	3.27	1.87	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	32.81	8.06	3.74	0.29	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	27.79	5.10	2.55	0.76	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	15.98	5.08	1.88	0.56	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	40.95	5.03	1.40	0.84	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	38.21	5.53	1.01	0.34	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.10	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	30.83	8.56	1.96	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	42.64	14.80	2.65	0.22	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	24.58	10.24	0.00	1.17	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.61	2.14	0.78	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.78	7.40	2.64	0.53	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.07	6.70	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.73	8.98	1.44	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	18.74	10.50	1.99	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	21.27	7.09	2.36	0.39	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.89	8.89	1.02	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	10.78	6.39	0.80	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	8.36	2.93	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	12.83	2.75	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	30.80	16.16	1.85	0.34	0.00	0.00
Synoviocyte, donor2	11368-117I9	22.46	6.87	1.34	0.34	0.00	0.00
Synoviocyte, donor3	11440-118H9	19.21	3.80	2.01	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	20.01	1.07	0.71	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	15.05	0.46	0.46	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	27.38	3.66	0.43	0.14	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	17.78	2.71	0.77	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	13.74	4.01	1.15	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	79.47	5.29	8.86	0.74	0.37	0.49
Urethra, donor2	10319-105A4	55.75	1.80	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	16.74	0.80	0.27	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	11.62	1.20	0.80	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	12.61	2.29	0.23	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	45.02	10.03	0.89	0.67	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	108.55	7.12	8.90	2.67	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	118.66	2.86	20.01	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	76.67	4.79	6.85	2.74	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	94.00	3.10	9.30	1.03	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	84.83	1.74	9.30	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	88.51	6.25	17.70	2.08	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	93.61	2.75	12.85	2.75	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	91.29	3.65	7.30	2.74	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	56.01	3.82	4.32	1.11	1.48	0.25
Wilms' tumor cell line:HFWT	10597-108E3	19.36	1.76	0.88	1.76	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	37.99	4.47	1.96	0.28	0.00	0.28
achilles tendon, donor2	10292-104G4	24.80	6.20	6.20	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	75.21	1.78	15.30	0.51	0.76	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	86.37	1.39	9.52	0.93	0.46	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	89.86	1.66	11.40	1.19	0.36	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	119.19	2.99	23.40	2.99	0.54	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	43.29	0.56	6.18	0.56	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	71.27	2.33	16.28	0.21	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	33.75	1.09	8.44	0.82	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	46.27	0.44	7.49	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	56.76	0.82	15.93	0.82	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	70.67	0.78	12.81	0.39	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	57.41	0.55	4.97	0.74	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	3.90	15.60	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	84.82	3.02	16.96	0.46	0.46	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	29.26	0.00	1.81	0.52	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	30.69	1.17	0.58	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	21.38	2.79	3.72	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	76.49	4.52	25.91	0.82	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	64.46	2.46	16.27	0.31	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	49.50	2.13	5.97	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	63.09	1.52	3.34	0.91	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	51.99	1.93	7.94	0.24	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	48.78	2.23	8.69	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	50.03	3.34	5.00	1.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	103.96	0.75	9.04	0.38	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	73.27	3.49	29.66	0.87	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	48.74	3.75	22.49	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	60.05	2.83	17.43	0.47	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	51.03	6.98	6.98	0.47	0.47	0.47
adipose, donor1	10184-103D4	43.98	24.04	2.35	1.17	2.93	0.00
adipose, donor2	10185-103D5	94.49	9.73	3.65	5.27	0.41	0.00
adipose, donor3	10186-103D6	62.08	7.35	2.72	2.18	0.82	0.27
adipose, donor4	10187-103D7	47.67	1.73	2.60	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	29.20	1.42	0.79	1.26	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	43.65	14.55	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	40.96	2.27	3.34	1.73	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	56.45	13.93	5.00	2.50	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	44.75	24.81	4.64	0.93	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	43.62	5.75	2.70	0.68	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	30.05	26.81	2.65	1.47	0.00	0.00
amygdala - adult, donor10196	10167-103B5	64.03	20.16	10.67	4.74	0.00	1.19
amygdala, adult, donor10252	10151-102I7	81.31	10.95	6.29	2.64	1.22	0.20
amygdala, newborn, donor10223	10360-105E9	36.80	9.68	4.52	2.58	2.26	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	53.99	9.55	2.67	0.64	0.13	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	71.70	10.59	10.15	1.32	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	74.82	5.34	8.35	1.34	0.00	0.33
aorta, adult, pool1	10052-101G7	40.01	8.43	1.77	0.98	0.39	0.59
appendix, adult	10189-103D9	80.34	7.76	14.36	0.39	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	33.36	1.72	3.44	0.69	0.00	0.00
artery, adult	10190-103E1	36.68	17.66	2.72	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	49.40	6.52	1.01	0.72	0.00	0.14
b cell line:RPMI1788	10427-106D4	52.94	2.08	7.88	1.34	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	41.06	16.09	1.66	0.28	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	37.91	5.06	1.98	0.10	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	50.55	2.51	3.35	0.50	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	54.25	1.68	5.59	0.56	0.56	0.56
bladder, adult, pool1	10011-101C2	55.19	8.37	4.24	1.63	0.22	0.00
blood, adult, pool1	10053-101G8	62.01	2.21	6.64	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	25.69	5.14	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	49.26	5.40	8.10	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	51.25	7.18	4.10	2.05	1.03	0.00
brain, adult, pool1	10012-101C3	84.19	12.81	4.45	3.45	0.56	0.45
brain, fetal, pool1	10085-102B4	90.83	2.67	13.36	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	40.30	7.93	8.26	1.98	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	30.96	2.00	1.75	1.12	0.12	0.00
breast, adult, donor1	10080-102A8	60.61	5.05	18.31	1.89	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	40.02	5.34	0.64	0.89	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	49.48	4.33	2.47	0.93	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	22.56	8.52	2.07	0.23	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	40.67	10.41	2.66	0.73	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	29.62	2.82	0.94	0.94	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	61.58	3.50	5.80	1.75	0.22	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	49.44	2.85	3.49	1.27	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	46.05	3.46	3.73	1.33	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	56.41	3.45	8.06	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	84.17	9.54	6.36	2.01	0.33	0.00
caudate nucleus, adult, donor10258	10379-105H1	46.61	11.46	6.11	1.53	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	32.23	7.32	4.03	0.00	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	58.27	8.74	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	98.00	2.99	6.41	2.78	1.07	0.21
cerebellum, adult, pool1	10083-102B2	41.39	2.41	3.10	1.72	1.03	0.00
cerebellum, newborn, donor10223	10357-105E6	39.02	7.47	4.15	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	62.03	10.59	5.04	4.03	0.76	0.25
cerebrospinal fluid, donor2	10294-104G6	32.89	6.58	1.46	1.46	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	35.37	1.44	1.44	0.29	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	110.04	22.87	3.65	1.16	0.17	0.00
cervix, adult, pool1	10013-101C4	57.74	7.35	3.78	1.99	0.52	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	47.65	9.89	5.99	0.84	0.56	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	11.76	2.61	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	83.39	11.68	9.07	3.23	0.87	0.50
choriocarcinoma cell line:SCH	10785-110H2	43.12	4.56	3.08	1.23	0.49	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	32.73	3.56	2.85	0.71	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	40.74	17.95	2.85	0.85	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	54.99	12.03	2.09	0.60	0.50	0.00
chorionic membrane cells, donor3	12240-129G8	53.85	25.28	3.85	0.55	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	61.60	2.02	17.17	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	73.77	1.92	23.05	1.15	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	67.16	4.86	7.60	0.84	0.00	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	37.24	3.08	1.80	0.77	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	42.81	1.69	2.66	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	44.18	1.83	0.81	0.41	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	52.71	1.18	2.94	1.18	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	76.36	0.78	7.30	0.26	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	34.74	3.43	2.06	0.23	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	28.98	5.21	2.60	0.17	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	23.98	1.83	1.28	0.55	0.55	0.18
colon carcinoma cell line:COLO-320	10420-106C6	89.32	4.56	4.18	3.80	0.38	0.00
colon, adult, donor1	10082-102B1	39.27	4.76	4.76	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	66.27	6.58	6.23	1.29	0.12	0.12
colon, fetal, donor1	10070-101I7	42.02	1.24	11.12	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	279.59	4.58	68.75	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	52.69	6.80	3.40	0.85	1.27	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	63.24	10.11	8.30	1.06	0.75	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	53.58	3.53	8.74	1.55	1.13	0.00
corpus callosum, adult, pool1	10042-101F6	74.30	3.54	2.65	3.10	1.00	0.22
cruciate ligament, donor2	10295-104G7	25.12	8.92	3.24	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	28.89	2.41	4.82	0.00	0.00	0.00
diencephalon, adult	10193-103E4	54.48	5.28	5.76	2.16	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	91.16	1.38	32.38	0.69	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	85.39	8.98	5.64	2.82	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	32.74	8.18	1.69	2.17	0.24	0.00
ductus deferens, adult	10196-103E7	69.77	6.98	11.96	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	47.53	2.88	5.76	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	50.76	5.15	8.83	0.00	0.74	0.74
dura mater, adult, donor1	10041-101F5	41.95	7.10	2.48	2.06	0.08	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	40.86	9.10	6.00	1.55	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	29.23	2.29	1.43	1.15	0.57	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	35.76	6.78	0.00	2.47	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	39.66	6.36	1.21	0.91	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	40.75	7.41	1.23	1.85	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	53.85	9.19	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	38.55	5.03	2.35	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	33.35	4.71	5.62	0.91	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	33.93	3.70	3.54	0.48	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	57.47	16.78	3.45	0.78	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	63.90	10.34	7.04	0.77	0.00	0.11
epididymis, adult	10197-103E8	44.37	6.70	6.70	1.26	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	35.13	10.11	2.31	0.89	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	27.13	5.11	0.79	0.39	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	73.65	5.37	7.21	0.79	0.39	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	51.08	5.31	5.31	0.79	0.20	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	78.76	5.27	8.07	1.34	0.22	0.56
esophagus, adult, pool1	10015-101C6	52.13	8.39	3.61	1.27	0.00	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	46.34	5.76	2.25	2.50	1.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	24.15	9.66	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	2.98	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	33.25	3.44	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	27.69	10.20	5.83	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	44.49	3.31	3.31	0.00	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	43.72	7.82	4.62	0.51	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	31.81	6.89	2.85	0.47	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	90.45	15.01	4.50	3.10	0.56	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	87.37	7.51	3.30	0.60	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	43.62	2.93	2.38	0.82	0.00	0.00
gall bladder, adult	10198-103E9	41.53	5.31	3.86	0.97	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	95.56	2.68	13.42	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	67.23	2.24	21.66	1.12	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	68.22	9.50	4.22	0.21	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	32.49	1.35	1.16	1.55	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	70.01	5.08	4.92	1.15	0.98	0.00
gastric cancer cell line:GSS	10560-108A2	25.63	2.75	2.75	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	62.60	2.06	9.37	1.14	0.23	0.23
giant cell carcinoma cell line:LU65	10487-107B1	17.78	2.41	0.23	1.15	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	37.65	7.56	1.26	1.12	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	75.82	10.48	11.22	1.75	0.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	70.72	12.46	10.77	1.69	0.32	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	90.86	13.48	10.11	0.84	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	34.11	3.20	1.21	1.21	0.33	0.00
glioma cell line:GI-1	10413-106B8	33.39	3.81	2.05	0.88	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	40.09	6.56	5.10	0.00	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	88.12	4.64	8.79	1.95	3.91	0.00
globus pallidus, adult, donor10258	10367-105F7	30.12	5.48	1.37	2.74	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	36.77	8.53	7.99	3.73	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	205.56	2.45	78.31	2.45	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	27.84	12.48	3.20	0.64	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	37.19	1.84	2.75	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	35.67	2.29	1.83	0.46	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	38.00	1.29	2.58	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	44.56	1.44	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	32.24	3.43	4.12	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	36.41	0.00	3.31	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	60.92	3.45	10.92	1.44	0.57	0.29
heart - mitral valve, adult	10205-103F7	41.86	4.78	4.19	1.49	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	39.48	5.23	3.92	1.57	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	83.26	19.98	11.66	3.33	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	42.24	7.35	4.29	0.20	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	43.43	6.81	5.11	2.13	0.00	0.00
heart, adult, pool1	10016-101C7	65.54	4.83	4.60	3.22	0.00	0.00
heart, fetal, pool1	10046-101G1	72.70	5.54	5.13	2.36	0.00	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	46.90	13.58	2.16	0.62	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	34.49	1.19	3.57	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	75.14	3.43	5.75	0.66	5.97	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	89.33	3.16	5.22	1.21	7.16	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	87.01	3.23	4.75	1.21	4.45	0.00
hepatoma cell line:Li-7	10484-107A7	52.27	2.67	2.67	0.78	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	64.82	2.21	5.03	1.21	0.10	0.20
hippocampus - adult, donor10196	10169-103B7	54.89	11.36	2.84	0.95	0.95	0.95
hippocampus, adult, donor10252	10153-102I9	85.52	7.96	6.53	2.25	1.02	0.00
hippocampus, adult, donor10258	10374-105G5	44.32	6.47	7.97	1.00	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	48.29	6.34	4.93	1.76	0.35	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	56.15	5.49	3.66	1.22	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	47.91	3.14	5.50	1.57	0.20	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	45.70	2.79	2.29	1.52	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	55.26	21.99	1.69	2.82	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	71.78	25.30	2.07	2.84	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	42.14	19.74	0.38	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	32.41	9.05	2.34	3.21	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	56.66	11.63	4.09	2.15	0.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	43.79	7.92	4.59	0.83	2.50	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	34.57	4.50	1.42	1.42	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	53.20	6.27	3.70	1.93	0.32	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	50.50	6.73	4.04	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	49.76	2.50	5.32	1.88	1.10	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	49.13	2.46	4.42	0.49	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.93	3.49	6.98	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	95.26	27.11	1.91	1.72	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	108.58	23.55	3.92	6.11	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	43.48	32.98	0.00	4.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	54.63	15.26	1.88	4.71	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	58.20	16.37	1.36	2.27	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	41.97	14.41	1.25	4.07	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	56.50	10.29	4.25	2.12	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	48.77	9.00	5.23	2.03	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	45.74	9.27	3.59	0.60	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	51.54	2.22	5.17	1.48	0.37	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	56.49	3.14	6.56	1.43	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	46.96	2.86	7.35	2.04	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	71.47	17.60	3.17	1.41	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	76.02	19.00	4.75	1.27	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	55.38	17.85	1.51	2.42	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	44.47	6.21	4.14	1.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	62.43	4.65	5.31	2.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	29.50	6.67	1.80	1.54	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	46.53	4.60	2.05	1.02	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	56.79	7.57	6.06	2.27	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	40.66	6.39	4.03	2.02	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	55.30	2.90	3.62	0.97	1.21	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	38.33	0.89	4.90	0.89	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	45.85	3.41	4.39	1.95	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	74.88	15.59	1.53	0.92	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	19.52	0.00	9.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	25.15	20.19	0.00	0.33	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	43.24	8.21	3.28	2.74	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	32.93	6.88	2.17	3.62	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	28.83	7.83	1.42	2.85	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	50.12	8.35	2.39	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	57.15	7.72	2.57	1.63	0.54	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	38.25	3.23	1.62	1.62	0.54	0.00
immature langerhans cells, donor1	11904-125F5	46.49	28.57	15.01	0.24	0.00	0.48
immature langerhans cells, donor2	11905-125F6	41.98	43.57	15.05	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	98.32	20.16	4.83	3.41	0.38	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	61.13	6.83	3.90	0.98	0.00	0.00
kidney, adult, pool1	10017-101C8	63.28	6.91	6.61	1.70	0.70	0.10
kidney, fetal, pool1	10045-101F9	61.19	3.68	4.46	1.49	0.21	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	63.20	14.63	4.54	0.85	0.43	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	29.72	5.81	2.21	1.24	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.46	7.52	2.94	1.47	0.55	0.37
left atrium, adult, donor1	10079-102A7	29.42	2.72	0.54	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	39.95	3.54	2.53	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	31.19	2.74	1.92	1.09	0.82	0.00
leiomyoma cell line:10964C	10569-108B2	20.84	12.57	1.80	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	15.76	13.59	3.26	0.54	0.54	0.54
leiomyoma cell line:15425	10571-108B4	22.10	11.90	1.94	0.49	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	19.05	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	41.82	10.46	8.36	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	76.38	9.44	9.09	0.47	0.00	0.12
liposarcoma cell line:KMLS-1	10782-110G8	29.06	8.75	1.09	0.31	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	42.40	3.41	3.53	0.61	0.24	0.00
liver, adult, pool1	10018-101C9	76.98	8.10	6.32	1.46	0.32	0.16
liver, fetal, pool1	10086-102B5	48.92	5.64	10.35	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	51.04	8.75	9.92	1.17	1.60	0.73
locus coeruleus, adult, donor10252	10165-103B3	90.80	6.09	8.30	1.85	2.58	0.55
locus coeruleus, adult, donor10258	10375-105G6	58.12	5.92	9.03	3.67	1.41	0.56
locus coeruleus, newborn, donor10223	10362-105F2	30.28	6.31	2.94	0.42	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	29.62	2.21	0.83	0.55	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	35.16	5.52	4.83	0.00	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	25.18	2.77	2.24	0.40	0.13	0.00
lung, adult, pool1	10019-101D1	62.84	6.38	5.08	0.95	0.12	0.00
lung, fetal, donor1	10068-101I5	87.33	2.57	13.98	1.14	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	70.11	5.50	8.25	0.46	0.46	0.00
lymph node, adult, donor1	10077-102A5	50.18	1.89	7.10	0.95	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	58.52	3.95	11.18	1.10	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	86.18	1.36	20.07	0.75	0.00	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	90.90	16.99	10.19	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	63.49	13.32	8.88	2.22	3.11	0.44
mature adipocyte, donor2	12232-129F9	74.50	7.89	9.55	0.62	2.28	0.62
mature adipocyte, donor3	12233-129G1	59.27	15.41	6.64	1.19	1.66	0.00
mature adipocyte, donor4	12234-129G2	53.43	15.53	8.42	0.53	2.37	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	61.71	8.10	6.91	2.38	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	90.24	14.66	11.28	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	94.71	13.06	7.17	1.66	0.92	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	45.11	9.85	5.40	2.86	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	36.25	13.22	5.12	0.85	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	64.46	20.59	8.61	2.36	0.34	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	88.50	15.92	7.00	2.55	1.27	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	50.08	0.00	13.48	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	40.92	8.26	1.08	1.44	1.44	0.36
medulla oblongata - adult, donor10196	10174-103C3	41.53	8.44	1.30	1.95	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	83.44	7.28	6.97	1.55	2.79	0.77
medulla oblongata, adult, pool1	10038-101F2	64.73	5.47	5.22	2.94	1.14	0.65
medulla oblongata, newborn, donor10223	10361-105F1	37.15	6.25	3.82	2.78	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	44.95	2.44	3.76	1.55	0.22	0.22
medulloblastoma cell line:ONS-76	10759-110E3	69.21	5.50	4.40	1.59	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	81.65	5.61	15.52	0.57	0.14	0.86
melanoma cell line:G-361	10465-106H6	62.44	13.84	2.44	1.09	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	33.83	5.07	2.17	0.54	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	57.28	4.41	15.86	2.64	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	94.88	1.30	10.63	2.85	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	31.15	12.43	2.45	0.61	0.15	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	29.63	9.45	0.91	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	24.43	9.52	2.07	0.83	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.65	9.41	1.55	0.84	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.42	9.24	0.58	0.96	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.96	7.63	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	19.74	12.19	2.23	0.00	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	26.45	5.98	1.38	0.46	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.82	7.43	1.59	0.40	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	38.89	12.15	2.43	0.41	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	47.66	12.38	2.13	0.43	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	27.01	9.88	1.98	0.66	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	37.64	13.01	1.52	0.42	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.09	5.93	1.40	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	31.24	13.88	1.22	0.61	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	21.21	9.71	1.80	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	25.55	9.93	1.14	0.62	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.24	11.40	3.19	0.00	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	39.44	13.85	1.68	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	31.68	10.46	1.64	0.15	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	32.04	7.70	2.01	0.61	0.18	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	24.67	10.68	1.47	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.90	10.87	3.15	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	31.16	8.84	0.84	0.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.55	5.02	1.83	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	17.90	5.12	0.77	0.00	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	22.77	3.93	1.83	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	20.33	4.01	0.62	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	21.18	5.18	0.94	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	23.02	6.43	3.05	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.83	4.72	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	20.85	4.63	1.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	25.09	5.77	2.60	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	25.88	6.02	1.34	0.67	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	21.15	5.53	1.20	0.72	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	27.13	5.87	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	17.79	4.70	1.34	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	23.74	4.50	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.18	6.01	0.86	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	14.94	5.85	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	2.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.99	5.86	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	4.91	1.64	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	14.38	8.16	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	4.20	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	17.88	5.96	0.00	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	12.45	5.34	1.19	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	4.87	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.67	6.97	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	17.94	7.24	1.03	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	6.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	12.63	4.07	1.22	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	13.51	1.59	2.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	13.56	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.34	3.43	0.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	4.01	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	26.02	2.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	24.78	2.75	2.07	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	43.54	3.96	7.92	0.49	5.94	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	44.86	3.36	10.09	1.12	7.85	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	47.70	3.82	6.36	0.00	6.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	59.64	3.63	7.66	2.01	8.06	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	56.70	6.54	6.54	0.00	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	30.41	0.00	12.67	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	40.66	9.10	5.46	0.00	2.43	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	13.56	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	36.24	2.47	9.06	0.82	4.94	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	29.96	3.57	2.98	0.60	1.19	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	31.15	4.22	4.22	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	33.61	3.06	4.07	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	31.72	5.42	2.32	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	38.98	4.96	0.71	1.18	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	54.21	10.66	5.33	0.23	0.46	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	8.55	8.55	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	47.16	12.02	6.78	0.21	0.21	0.10
mesothelioma cell line:Mero-25	10850-111F4	79.43	4.31	10.21	1.59	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	48.65	8.80	2.20	1.22	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	41.63	8.86	6.86	0.44	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	65.70	15.24	11.04	1.05	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	48.17	10.89	7.83	0.51	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	54.09	6.32	8.09	0.00	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	42.86	7.45	8.07	1.04	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	41.08	13.09	3.98	0.83	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	43.26	7.42	7.60	0.54	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	24.94	4.95	1.20	0.68	0.34	0.34
mesothelioma cell line:NCI-H28	10845-111E8	51.66	7.38	7.63	1.27	0.51	0.00
mesothelioma cell line:No36	10857-111G2	30.34	2.61	4.24	0.33	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	77.76	15.44	14.09	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	46.83	3.84	6.91	0.38	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	56.54	4.27	7.20	0.73	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	52.23	4.31	6.82	0.36	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	53.22	3.59	1.31	0.00	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	24.58	2.76	0.42	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	49.30	11.75	5.53	1.15	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	42.05	3.81	5.90	0.57	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	53.96	2.59	2.77	0.74	0.37	0.00
myeloma cell line:PCM6	10474-106I6	49.22	3.36	3.36	0.40	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	26.89	13.70	2.54	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	53.55	18.04	4.32	1.37	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	40.00	4.79	0.11	1.00	0.00	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	30.89	5.15	0.88	0.44	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	42.50	7.73	0.55	2.76	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	103.53	4.60	13.34	1.38	0.46	0.92
neuroblastoma cell line:NB-1	10539-107G8	84.00	2.06	9.92	2.43	0.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	64.32	3.80	7.80	0.84	0.84	0.21
neuroblastoma cell line:NH-12	10555-107I6	73.61	1.12	6.34	1.86	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	66.90	0.95	17.08	1.19	0.71	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	61.93	10.45	5.86	1.27	1.43	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	23.95	0.40	1.41	0.60	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	36.87	0.64	0.64	1.91	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	33.80	10.65	2.40	0.53	0.00	0.53
neutrophil PMN, donor1	12133-128D9	89.25	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	85.24	0.00	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	196.69	2.37	31.12	1.18	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	46.43	0.80	10.41	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	27.25	5.45	2.56	0.32	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.28	3.42	2.36	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	85.68	12.94	6.09	2.62	0.84	0.09
occipital cortex - adult, donor10196	10172-103C1	67.99	49.45	6.18	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	93.12	10.73	9.12	1.61	2.42	0.27
occipital cortex, newborn, donor10223	10355-105E4	43.67	15.29	6.55	2.55	0.36	1.09
occipital lobe, adult, donor1	10076-102A4	92.89	18.89	5.51	2.62	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	86.68	7.72	4.72	3.86	0.43	0.00
occipital pole, adult, pool1	10036-101E9	80.50	12.54	4.57	3.23	0.47	0.32
olfactory region, adult	10195-103E6	64.38	11.27	4.01	1.72	0.38	0.00
optic nerve, donor1	10277-104E7	42.02	8.00	6.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	78.03	22.90	6.95	1.94	0.46	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	52.07	1.65	0.82	1.37	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	37.59	6.26	1.19	0.68	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	81.55	15.13	2.77	1.04	0.00	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	29.69	13.23	2.65	0.59	0.00	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	56.06	14.02	4.67	3.74	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	57.89	3.82	3.61	0.85	0.64	0.21
ovary, adult, pool1	10020-101D2	51.10	2.01	3.14	1.75	0.09	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	27.31	6.78	1.83	0.37	0.00	0.00
pancreas, adult, donor1	10049-101G4	53.62	6.58	5.64	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	58.14	5.87	4.47	0.84	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	57.92	6.47	8.18	0.68	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	68.72	14.57	5.46	0.83	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	99.03	13.55	4.21	2.75	0.46	0.27
parietal cortex, adult, donor10258	10373-105G4	29.36	5.14	3.67	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	63.01	20.69	5.64	2.82	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	94.63	14.82	9.12	1.43	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	98.43	13.39	5.20	3.70	0.35	0.18
parietal lobe, fetal, donor1	10072-101I9	88.25	4.85	7.76	3.88	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	41.50	11.96	7.48	0.37	3.36	0.00
parotid gland, adult	10199-103F1	40.70	3.08	7.40	0.00	0.00	0.62
penis, adult	10200-103F2	32.23	11.28	4.30	1.61	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	79.77	3.90	12.46	2.23	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	54.20	3.35	2.33	0.87	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	78.05	10.97	8.39	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	139.17	4.15	14.21	1.18	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	61.45	6.27	15.05	0.63	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	64.76	11.13	9.11	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	158.96	11.47	6.25	1.56	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	42.56	5.11	0.85	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	64.72	7.74	10.64	1.40	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	51.78	2.65	7.68	0.79	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	78.91	10.89	7.63	1.40	0.00	0.16
pons, adult, pool1	10033-101E6	92.35	11.71	6.37	4.39	1.46	0.69
postcentral gyrus, adult, pool1	10032-101E5	85.26	14.99	4.27	2.88	0.52	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	140.12	10.46	37.65	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	50.25	6.26	2.91	1.02	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	46.28	5.08	1.27	0.54	0.00	0.18
prostate, adult, pool1	10022-101D4	50.33	3.36	4.63	1.54	0.18	0.09
putamen, adult, donor10196	10176-103C5	114.73	19.83	7.79	1.42	0.94	0.24
putamen, adult, donor10252	10152-102I8	41.18	5.88	3.92	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	4.37	9.84	2.19	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	51.22	10.39	3.87	2.42	0.24	0.24
putamen, newborn, donor10223	10365-105F5	24.74	5.25	2.25	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	43.06	1.16	4.36	0.58	0.58	0.00
rectum, fetal, donor1	10067-101I4	51.47	4.17	6.95	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	29.47	5.94	1.70	0.21	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	47.63	14.91	4.97	1.24	0.00	0.41
retina, adult, pool1	10030-101E3	48.41	4.17	3.18	1.79	0.50	0.20
retinoblastoma cell line:Y79	10475-106I7	65.73	2.60	4.68	2.08	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	37.50	2.46	1.11	1.35	1.35	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	50.05	1.97	1.41	1.97	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.95	6.82	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	21.37	13.92	1.46	0.65	0.16	0.00
salivary acinar cells, donor2	11772-123I8	17.07	13.36	0.96	0.55	0.00	0.14
salivary acinar cells, donor3	11773-123I9	19.20	8.61	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	47.47	6.86	5.15	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	39.80	9.02	1.10	1.43	0.00	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	45.96	8.23	1.76	1.29	0.12	0.00
seminal vesicle, adult	10201-103F3	70.37	11.11	8.99	1.06	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	44.94	22.83	8.99	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	31.45	12.58	4.53	0.75	1.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	55.19	5.02	6.02	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	54.53	11.55	5.24	1.07	0.40	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	61.12	6.74	2.87	1.11	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	43.87	4.77	4.52	0.26	0.00	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	17.02	14.19	1.42	2.84	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	70.28	29.26	5.40	4.56	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	27.14	3.02	2.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	47.50	13.57	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	29.04	3.16	3.79	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	110.40	5.00	6.00	2.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	76.91	7.56	12.61	2.52	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	27.18	0.77	0.58	3.47	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	110.93	6.26	6.43	2.14	0.00	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	53.24	2.90	3.54	5.31	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	81.94	6.32	7.85	2.18	0.00	0.00
small intestine, adult, pool1	10024-101D6	81.58	9.20	12.78	1.31	0.12	0.00
small intestine, fetal, donor1	10064-101I1	37.59	2.70	7.37	0.25	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	64.11	7.18	14.36	2.05	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	41.09	6.72	1.55	1.29	0.00	0.52
somatostatinoma cell line:QGP-1	10781-110G7	64.06	7.77	4.82	0.27	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	43.36	5.51	6.88	0.92	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	74.12	6.70	7.89	1.18	1.18	1.18
spinal cord, adult, donor10258	10369-105F9	20.75	0.69	2.77	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	46.96	3.66	4.88	1.22	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	34.44	7.81	4.59	0.92	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	36.59	14.64	1.64	0.75	0.00	0.15
spleen, adult, pool1	10025-101D7	73.35	3.30	6.50	0.22	0.11	0.00
spleen, fetal, pool1	10044-101F8	74.45	5.56	9.61	0.72	0.00	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	48.65	2.28	4.66	0.31	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	46.71	7.41	1.33	0.38	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	39.84	6.29	3.49	0.35	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	65.68	19.94	3.52	1.17	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	48.74	5.40	1.13	1.13	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	36.01	5.51	2.97	1.69	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	79.96	17.35	12.69	1.69	0.00	0.00
stomach, fetal, donor1	10062-101H8	45.92	18.16	5.34	2.14	0.00	0.00
submaxillary gland, adult	10202-103F4	45.00	4.56	2.85	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	84.54	3.74	5.19	1.45	2.08	0.00
substantia nigra, adult, donor10258	10371-105G2	28.97	1.55	5.17	2.07	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	22.61	7.07	1.41	1.41	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	80.24	3.67	5.27	2.98	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	85.79	9.92	3.73	2.97	0.08	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	64.82	1.42	2.85	2.14	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	54.94	2.64	4.40	0.00	0.00	0.44
tenocyte, donor1	11763-123H8	39.80	5.93	1.40	1.05	0.00	0.00
tenocyte, donor2	11765-123I1	19.84	9.54	2.67	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	27.06	7.78	0.37	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	74.61	1.87	3.06	3.06	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	56.26	3.08	4.16	1.70	0.46	0.00
teratocarcinoma cell line:PA-1	10807-111A6	47.73	0.77	2.01	1.24	0.62	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	93.56	4.19	15.23	2.29	1.02	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	82.82	4.92	5.67	0.76	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	114.84	12.21	21.38	3.49	0.65	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	134.84	10.10	7.17	3.58	0.65	0.33
testis, adult, pool1	10026-101D8	66.03	4.40	3.87	6.55	0.54	0.21
testis, adult, pool2	10096-102C6	44.66	5.86	8.57	8.12	0.90	0.00
thalamus - adult, donor10196	10168-103B6	65.14	6.62	3.31	3.31	0.00	1.10
thalamus, adult, donor10252	10154-103A1	81.42	3.44	4.06	1.56	0.94	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	44.65	3.08	20.02	3.08	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	52.54	5.76	7.08	1.48	0.33	0.33
thalamus, newborn, donor10223	10366-105F6	33.37	13.81	5.18	1.15	0.00	0.00
throat, adult	10209-103G2	33.71	8.24	3.75	1.50	0.00	0.50
throat, fetal, donor1	10061-101H7	46.01	2.74	8.53	0.61	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	43.32	1.19	1.99	1.79	0.40	0.00
thymus, adult, pool1	10027-101D9	156.98	3.38	29.82	2.19	0.00	0.40
thymus, fetal, pool1	10043-101F7	140.27	5.82	22.55	1.56	0.10	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	37.76	13.03	3.32	1.06	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	58.53	7.82	3.63	0.98	0.14	0.14
thyroid, adult, pool1	10028-101E1	62.80	4.76	4.20	1.96	0.84	0.19
thyroid, fetal, donor1	10060-101H6	51.94	5.01	8.70	0.53	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	9.24	9.24	0.00	0.00	0.00
tongue, adult	10203-103F5	30.93	8.84	3.02	0.93	0.00	0.00
tongue, fetal, donor1	10059-101H5	48.08	3.94	7.09	0.79	0.00	0.00
tonsil, adult, pool1	10047-101G2	84.15	7.01	9.62	1.10	0.20	0.30
trachea, adult, pool1	10029-101E2	59.79	6.87	5.32	0.90	0.25	0.08
trachea, fetal, donor1	10058-101H4	51.55	2.69	8.08	1.15	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	25.51	13.46	1.77	0.71	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	58.26	5.17	2.63	1.42	0.00	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	68.47	16.45	2.66	1.41	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	13.32	7.61	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	43.17	6.18	2.96	1.02	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	20.87	2.09	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	57.16	6.14	5.46	1.54	0.34	0.00
uterus, fetal, donor1	10055-101H1	49.66	7.17	2.05	1.54	0.00	0.00
vagina, adult	10204-103F6	56.22	3.23	9.69	3.23	0.00	0.65
vein, adult	10191-103E2	59.40	6.36	13.59	0.66	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	33.91	1.60	3.47	0.00	0.00	0.27